Anthony Gringeri, Senior VP Strategic Resources at ImmunoCellular Therapeutics, Ltd. (IMUC), bought 30,000 shares at $0.60 ($18K) on 2015-02-18, disclosed to the SEC on 2015-02-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.